Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $223,488 - $287,831
482 New
482 $239,000
Q3 2020

Nov 02, 2020

SELL
$454.43 - $535.6 $10,451 - $12,318
-23 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $1,339 - $1,972
4 Added 21.05%
23 $10,000
Q1 2020

May 18, 2020

BUY
$320.01 - $409.07 $6,080 - $7,772
19 New
19 $7,000
Q3 2019

Nov 15, 2019

SELL
$304.55 - $345.24 $1,827 - $2,071
-6 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$286.93 - $312.59 $1,721 - $1,875
6 New
6 $2,000
Q1 2018

May 16, 2018

SELL
$233.97 - $274.11 $2,807 - $3,289
-12 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$212.27 - $242.28 $2,547 - $2,907
12
12 $3,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.46B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Balentine LLC Portfolio

Follow Balentine LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.